Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Medical technology & services

Optibiotix appoints Dr Tim Spector as science advisor

Spector’s appointment creates opportunities to collaborate and additional insight into the role of the microbiome in health and disease, Optibiotix highlighted.

Optibiotix (LON:OPTI) has appointed microbe and genetics specialist Dr Tim Spector to its Scientific Advisory Group (SAG).

The new advisor is the author of 'The Diet Myth' book as well as over 700 academic papers, and he is a consultant physician at Guys and St Thomas's Hospital, London, and director of the British Gut project.

'The Diet Myth' summarises scientific studies into how gut bacteria affect our body weight and general health, Optibiotix highlighted.

Spector’s appointment creates opportunities to collaborate and additional insight into the role of the microbiome in health and disease, it added.

"I am delighted that Tim has agreed to join our scientific advisory group,” said Stephen O'Hara, OptiBiotix chief executive.

“His research interests in the microbiome open up the potential for new collaborations and development opportunities.

“Tim's ability to communicate complex scientific data to a wider public, as exemplified by his book 'The Diet Myth', will bring an increased consumer focus to our scientific advisory group."

City broker Hybridan described it as a “very profile and world class” appointment.

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK